Lansdowne Partners

Type

Other

Status

Active

Location

London, United Kingdom

Total investments

39

Average round size

51M

Portfolio companies

27

Rounds per year

1.50

Lead investments

2

Follow on index

0.31

Exits

5

Stages of investment
Private EquityLate Stage Venture
Areas of investment
BiotechnologyInformation TechnologyHealth CareGeneticsMedicalLife ScienceTherapeuticsEnergyRenewable EnergyBiopharma

Summary

Lansdowne Partners appeared to be the VC, which was created in 1998. The main office of represented VC is situated in the London. The company was established in Europe in United Kingdom.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Lansdowne Partners, startups are often financed by IP Group Plc, Invesco, Woodford Investment Management. The meaningful sponsors for the fund in investment in the same round are Invesco, IP Group Plc, Woodford Investment Management. In the next rounds fund is usually obtained by IP Group Plc, Woodford Investment Management, Invesco.

The overall number of key employees were 7.

The fund is constantly included in less than 2 deals per year. Comparing to the other companies, this Lansdowne Partners performs on 10 percentage points less the average number of lead investments. Deals in the range of 50 - 100 millions dollars are the general things for fund. The higher amount of exits for fund were in 2018. The typical startup value when the investment from Lansdowne Partners is more than 1 billion dollars. The high activity for fund was in 2014. Speaking about the real fund results, this VC is 14 percentage points less often commits exit comparing to other organizations.

For fund there is a match between the location of its establishment and the land of its numerous investments - United Kingdom. The fund has specific favorite in a number of founders of portfolio startups. Among the most successful fund investment fields, there are Pharmaceutical, Internet of Things. Among the most popular portfolio startups of the fund, we may highlight Spotify, benevolent.ai, Oxford Nanopore Technologies. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund.

Show more

Investor highlights

Stage focus
Seed

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
39
Lead investments
2
Exits
5
Rounds per year
1.50
Follow on index
0.31
Investments by industry
  • Biotechnology (18)
  • Health Care (9)
  • Genetics (8)
  • Biopharma (7)
  • Therapeutics (6)
  • Show 50 more
Investments by region
  • United Kingdom (26)
  • Malta (4)
  • United States (4)
  • France (1)
  • Austria (2)
  • Show 2 more
Peak activity year
2022
Number of Unicorns
1
Number of Decacorns
1
Number of Minotaurs
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
10
Avg. valuation at time of investment
196M
Group Appearance index
0.97
Avg. company exit year
5
Avg. multiplicator
12.71
Strategy success index
0.50

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
21 Jun 2021 Medical Device Early Stage Venture 3M Chile, Los Lagos Region, Chile
Oxford Quantum Circuits 27 Nov 2023 Biotechnology, Information Technology, Health Care, Information and Communications Technology (ICT) Early Stage Venture 100M Oxfordshire, Oxford, United Kingdom
Pollen 20 Apr 2022 Marketplace, Marketing, Events, Travel, Ticketing, Customer Service, Adventure Travel Late Stage Venture 169M England, London, United Kingdom

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.